Terumo Corporation (TYO:4543)
Japan
· Delayed Price · Currency is JPY 2,416.50
-31.00 (-1.27%)
Sep 29, 2025, 3:30 PM JST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2012 - 2020 |
| Cardiac and Vascular Company | 624.36B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiac and Vascular Company Growth | 7.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Care Solutions Company | 211.24B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Care Solutions Company Growth | 2.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Blood and Cell Technologies Company | 200.28B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Blood and Cell Technologies Company Growth | 14.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 1.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Adjustments from | 298.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Adjustments from Growth | 28.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 1.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2012 - 2020 |
| Other | 3.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas | 395.65B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas Growth | 14.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 218.29B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 8.58% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 84.97B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 2.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia and Others | 120.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia and Others Growth | 2.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan | 217.21B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | 0.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 3.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is April - March.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2012 - 2020 |
| Cardiac and Vascular Company Adjusted Operating Profit | 154.68B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiac and Vascular Company Adjusted Operating Profit Growth | 22.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Care Solutions Company Adjusted Operating Profit | 22.99B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Care Solutions Company Adjusted Operating Profit Growth | 2.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Blood and Cell Technologies Company Adjusted Operating Profit | 26.48B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Blood and Cell Technologies Company Adjusted Operating Profit Growth | 3.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Adjustments from Adjusted Operating Profit | -712.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Adjustments from Adjusted Operating Profit Growth | -145.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiac and Vascular Company Production Result | 620.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiac and Vascular Company Production Result Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Care Solutions Company Production Result | 197.08B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Care Solutions Company Production Result Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Blood and Cell Technologies Company Production Result | 205.67B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Blood and Cell Technologies Company Production Result Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|